About the authors
Алымжан уулу Болотбек, ассистент кафедры неврологии с курсом медицинской генетики Кыргызской государственной медицинской академии им. И.К. Ахунбаева, Бишкек, Кыргызская Республика
Исраилова Айчолпон Тагайбековна, ассистент кафедры Неврологии и клинической генетики Кыргызской государственной медицинской академии им. И.К. Ахунбаева, Бишкек, Кыргызская Республика
Жолдошев Эмир Кылычбекович, завуч кафедры кафедры Неврологии и клинической генетики Кыргызской государственной медицинской академии им. И.К. Ахунбаева, Бишкек, Кыргызская Республика
Alymjan uulu Bolotbek, assistant at the Department of Neurology with a course in medical genetics, Kyrgyz State Medical Academy named after I.K. Akhunbaeva, Bishkek, Kyrgyz Republic
Israilova Aicholpon Tagaybekovna, assistant of the Department of Neurology and Clinical Genetics of the Kyrgyz State Medical Academy named after I.K. Akhunbaeva, Bishkek, Kyrgyz Republic
Zholdoshev Emir Kylychbekovich, Head of the Department of Neurology and Clinical Genetics of the Kyrgyz State Medical Academy named after I.K. Akhunbaeva, Bishkek, Kyrgyz Republic
Алымжан уулу Болотбек, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын медициналык генетика курсу менен неврология кафедрасынын ассистенти, Бишкек, Кыргыз Республикасы
Исраилова Айчолпон Тагайбековна, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын неврология жана клиникалык генетика кафедрасынын ассистенти, Бишкек, Кыргыз Республикасы
Эмир Кылычбекович Жолдошев, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын неврология жана клиникалык генетика кафедрасынын башчысы, Бишкек, Кыргыз Республикасы
References
1. Jeffery DR, Mandler RN, Davis LE. Transverse Myelitis: Retrospective Analysis of 33 Cases, With Differentiation of
Cases Associated With Multiple Sclerosis and Parainfectious Events. Arch Neurol. 1993;50(5):532–535. doi:10.1001/archneur.1993.00540050074019
2. Krishnan C, Kaplin AI, Pardo CA, Kerr DA, Keswani SC. Demyelinating disorders: update on transverse myelitis.Curr
Neurol Neurosci Rep. 2006 May;6(3):236-43. doi: 10.1007/s11910-006-0011-1. PMID: 16635433.
3. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A,
Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG;
International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum
disorders. Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.PMID: 260
92914; PMCID: PMC4515040.
4. Krishnan C, Kaplin AI, Pardo CA, et al.. Demyelinating disorders: update on transverse myelitis. Curr Neurol Neurosci
Rep 2006;6:236–43. 10.1007/s11910-006-0011-1.
5. Johns JS, Krogh K, Ethans K, et al..Pharmacological management of neurogenic bowel dysfunction after spinal cord
injury and multiple sclerosis:a systematic review and clinical implications. J Clin Med 2021;10:882.10.3390/jcm1004088
2.
6. Emmanuel A. Neurogenic bowel dysfunction. F1000Res.2019 Oct 28;8:F1000 Faculty Rev-1800. doi: 10.12688/f1000
research.20529.1. PMID:31700610; PMCID: PMC6820819.
7. Hughes M. Bowel management in spinal cord injury patients. Clin Colon Rectal Surg 2014;27:113–5. 10.1055/s-0034-
1383904
8. Alavi K, Poylin V, Davids JS, et al.. The American Society of colon and rectal surgeons clinical practice guidelines for
the management of colonic volvulus and acute colonic pseudo-obstruction. Dis Colon Rectum 2021;64:1046–57.10.
1097 /DCR.0000000000002159
1. Jeffery DR, Mandler RN, Davis LE. Transverse Myelitis: Retrospective Analysis of 33 Cases, With Differentiation of
Cases Associated With Multiple Sclerosis and Parainfectious Events. Arch Neurol. 1993;50(5):532–535. doi:10.1001/archneur.1993.00540050074019
2. Krishnan C, Kaplin AI, Pardo CA, Kerr DA, Keswani SC. Demyelinating disorders: update on transverse myelitis.Curr
Neurol Neurosci Rep. 2006 May;6(3):236-43. doi: 10.1007/s11910-006-0011-1. PMID: 16635433.
3. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A,
Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG;
International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum
disorders. Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.PMID: 260
92914; PMCID: PMC4515040.
4. Krishnan C, Kaplin AI, Pardo CA, et al.. Demyelinating disorders: update on transverse myelitis. Curr Neurol Neurosci
Rep 2006;6:236–43. 10.1007/s11910-006-0011-1.
5. Johns JS, Krogh K, Ethans K, et al..Pharmacological management of neurogenic bowel dysfunction after spinal cord
injury and multiple sclerosis:a systematic review and clinical implications. J Clin Med 2021;10:882.10.3390/jcm1004088
2.
6. Emmanuel A. Neurogenic bowel dysfunction. F1000Res.2019 Oct 28;8:F1000 Faculty Rev-1800. doi: 10.12688/f1000
research.20529.1. PMID:31700610; PMCID: PMC6820819.
7. Hughes M. Bowel management in spinal cord injury patients. Clin Colon Rectal Surg 2014;27:113–5. 10.1055/s-0034-
1383904
8. Alavi K, Poylin V, Davids JS, et al.. The American Society of colon and rectal surgeons clinical practice guidelines for
the management of colonic volvulus and acute colonic pseudo-obstruction. Dis Colon Rectum 2021;64:1046–57.10.
1097 /DCR.0000000000002159
1. Jeffery DR, Mandler RN, Davis LE. Transverse Myelitis: Retrospective Analysis of 33 Cases, With Differentiation of
Cases Associated With Multiple Sclerosis and Parainfectious Events. Arch Neurol. 1993;50(5):532–535. doi:10.1001/archneur.1993.00540050074019
2. Krishnan C, Kaplin AI, Pardo CA, Kerr DA, Keswani SC. Demyelinating disorders: update on transverse myelitis.Curr
Neurol Neurosci Rep. 2006 May;6(3):236-43. doi: 10.1007/s11910-006-0011-1. PMID: 16635433.
3. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A,
Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG;
International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum
disorders. Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.PMID: 260
92914; PMCID: PMC4515040.
4. Krishnan C, Kaplin AI, Pardo CA, et al.. Demyelinating disorders: update on transverse myelitis. Curr Neurol Neurosci
Rep 2006;6:236–43. 10.1007/s11910-006-0011-1.
5. Johns JS, Krogh K, Ethans K, et al..Pharmacological management of neurogenic bowel dysfunction after spinal cord
injury and multiple sclerosis:a systematic review and clinical implications. J Clin Med 2021;10:882.10.3390/jcm1004088
2.
6. Emmanuel A. Neurogenic bowel dysfunction. F1000Res.2019 Oct 28;8:F1000 Faculty Rev-1800. doi: 10.12688/f1000
research.20529.1. PMID:31700610; PMCID: PMC6820819.
7. Hughes M. Bowel management in spinal cord injury patients. Clin Colon Rectal Surg 2014;27:113–5. 10.1055/s-0034-
1383904
8. Alavi K, Poylin V, Davids JS, et al.. The American Society of colon and rectal surgeons clinical practice guidelines for
the management of colonic volvulus and acute colonic pseudo-obstruction. Dis Colon Rectum 2021;64:1046–57.10.
1097 /DCR.0000000000002159